Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
IL17-producing Th17 cells, generated through a STAT3-dependent mechanism, have been shown to promote carcinogenesis in many systems, including microbe-driven colon cancer. Additional sources of IL17, such as γδ T cells, become available under inflammatory conditions, but their contributions to cancer development are unclear. In this study, we modeled Th17-driven colon tumorigenesis by colonizing Min(Ap) (c+/-) mice with the human gut bacterium, enterotoxigenic Bacteroides fragilis (ETBF), to investigate the link between inflammation and colorectal cancer. We found that ablating Th17 cells by knocking out Stat3 in CD4(+) T cells delayed tumorigenesis, but failed to suppress the eventual formation of colonic tumors. However, IL17 blockade significantly attenuated tumor formation, indicating a critical requirement for IL17 in tumorigenesis, but from a source other than Th17 cells. Notably, genetic ablation of γδ T cells in ETBF-colonized Th17-deficient Min mice prevented the late emergence of colonic tumors. Taken together, these findings support a redundant role for adaptive Th17 cell- and innate γδT17 cell-derived IL17 in bacteria-induced colon carcinogenesis, stressing the importance of therapeutically targeting the cytokine itself rather than its cellular sources. Cancer Res; 76(8); 2115-24. ©2016 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recent study demonstrated that IL-17 produced in response to ETBF colonization in the intestine of MinApc+/Δ716 mice promotes colon cancer initiation and progression”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Housseau et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812 · cited 10×
“These findings underline a likely combined impact of IL-17 on ETBF-mediated tumor initiation and tumor growth (2).”
InfluentialSelf-citationIL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703
Innate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553 · cited 3×
“Early γδT17 cells have been shown to be important for triggering and amplifying the ensuing adaptive Th17 immune response (17).”
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487
Self-citationTosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146 · cited 9×
“IL-17-producing cells in human CRC samples.”
InfluentialPivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V. R., Zhang, H.-G., Wang, T., Zheng, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.001 · Cited by 1,026
Martin, B., Hirota, K., Cua, D. J., Stockinger, B., & Veldhoen, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.020 · Cited by 822 · cited 2×
“Non-Th17-derived IL-17 is thought to be mainly provided early by innate cells at mucosal and skin surfaces in response to infection and serves to determine the amplitude of the ensuing adaptive Th17 immune response (10, 14).”
Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22
Takatori, H., Kanno, Y., Watford, W. T., Tato, C. M., Weiss, G., Ivanov, I. I., Littman, D. R., & O'Shea, J. J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20072713 · Cited by 740 · cited 1×
“However, though macroscopic colon tumors were decreased 2 months after ETBF colonization, colon tumorigenesis rebounded and Il17a was highly expressed in tumor tissues suggesting that non-CD4 T cells (therefore not Th17, Treg or LTi) infiltrating colon tumors were producing IL-17 (29).”
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625 · cited 2×
“ETBF is an anaerobe detected in up to 50% of individuals, without clinical symptoms (4, 5).”
Self-citation
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“A recent study demonstrated that IL-17 produced in response to ETBF colonization in the intestine of MinApc+/Δ716 mice promotes colon cancer initiation and progression (Housseau et al., 2016).”
BackgroundThe Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.004 · Cited by 777
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706
“However, IL-17 is redundantly produced by other immune cell populations, including γδ T cells [122] and innate lymphoid cells type 3 (ILC3) [123].”
BackgroundChung, L., Thiele Orberg, E., Geis, A. L., Chan, J. L., Fu, K., DeStefano Shields, C. E., Dejea, C. M., Fathi, P., Chen, J., Finard, B. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.01.007 · Cited by 644
“In our model of de novo ETBF-induced tumorigenesis, we previously established that IL-17 is required for colon tumor development in colonized ApcMin mice (Housseau et al., 2016; Wu et al., 2009).”
InfluentialGenetic and biological hallmarks of colorectal cancer
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 573
“Interestingly, if treated with the antibiotic cefoxitin, ETBF can be eliminated inmurinemodels followed by reduced tumorigenesis and IL-17A expression, indicating that ETBF plays a role in Th17 response (DeStefano Shields et al. 2016; Housseau et al. 2016).”
Background
Metadata
- Authors
- Housseau, F., Wu, S., Wick, E. C., Fan, H., Wu, X., Llosa, N. J., Smith, K. N., Tam, A., Ganguly, S., Wanyiri, J. W., Iyadorai, T., Malik, A. A., Roslani, A. C., Vadivelu, J. S., Van Meerbeke, S., Huso, D. L., Pardoll, D. M., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- University of Malaya (MY)
- 2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Corresponding author
- Housseau, Franck
- ORCID
- Venue
- Cancer Research
- Published
- 2016-04-14
- Volume
- 76
- Issue
- 8
- Pages
- 2115-2124
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC4873376
- OpenAlex
- W2288145373
- Cited by
- 143
- References
- 39
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 7 · 2023: 16 · 2022: 14 · 2021: 17 · 2020: 16 · 2019: 22 · 2018: 12 · 2017: 16 · 2016: 5
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (RO1CA151393, R01DK080817, R01CA151325, P30DK089502, P30CA006973, K08 DK087856)
- University of Malaya Research (UMRG RP016A-13HTM)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-17, Th17 cells, γδ T cells, colon tumorigenesis, colorectal cancer, Bacteroides fragilis, enterotoxigenic Bacteroides fragilis, ApcMin/+ mice, STAT3, gut microbiota, inflammation-associated carcinogenesis
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunity, Innate, Mice, Inbred C57BL, CD4 Antigens, Interleukin-17, Mice, Adaptive Immunity, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis. https://app.cochat.ai/papers/10.1158/0008-5472.can-15-0749
- The paper
- Housseau, F., Wu, S., Wick, E. C., Fan, H., Wu, X., Llosa, N. J., Smith, K. N., Tam, A., Ganguly, S., Wanyiri, J. W., Iyadorai, T., Malik, A. A., Roslani, A. C., Vadivelu, J. S., Van Meerbeke, S., Huso, D. L., Pardoll, D. M., & Sears, C. L. (2016). Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis. Cancer Research. https://doi.org/10.1158/0008-5472.can-15-0749
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.